Moreover, by immunofluorescence, we demonstrated that GA treatment remarkably reduced the M2 CD206+ cell number in the tumor tissues, while the M1 CD86+ cell number increased in the TME (Figure 6C). This evidence concerns the gene CD86 and neoplasm.